Caterina Minniti
Pediatric Hematology-Oncology · Washington, DCNPI 1396824454
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $377,026 of the $478,199 with a category attached, or 78.8%. It is spread thinly across 17 manufacturers, the largest accounting for just 21.5%. Among pediatric hematology-oncology clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $2106.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$103K
- Emmaus Medical, Inc.$90K
- Pfizer$87K
- Novo Nordisk$70K
- Chiesi USA, Inc.$23K
- Agios Pharmaceuticals, Inc.$21K
- plus $83K from 11 others
Across 109 payments — averaging $5679.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$420K
- Agios Pharmaceuticals, Inc.$145K
- Global Blood Therapeutics, Inc.$46K
- F. Hoffmann-la Roche AG$7K
- Pfizer$2K
What the payments were for
- Consulting fees$377,02679%
- Speaking & faculty fees$54,59211%
- Travel & lodging$33,0427%
- Food & beverage$13,5393%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 37 | $102,742 |
| Emmaus Medical, Inc. | 29 | $90,143 |
| Pfizer | 40 | $87,015 |
| Novo Nordisk | 27 | $70,414 |
| Chiesi USA, Inc. | 5 | $23,280 |
| Agios Pharmaceuticals, Inc. | 26 | $21,114 |
| CSL Behring | 14 | $20,298 |
| Vertex | 14 | $15,265 |
| AstraZeneca | 6 | $10,650 |
| Novartis | 10 | $9,343 |
| Merck | 9 | $7,106 |
| Genetix Biotherapeutics Inc | 1 | $6,660 |
| F. Hoffmann-la Roche AG | 4 | $5,060 |
| Sanofi | 1 | $4,598 |
| Novo Nordisk Health Care AG | 2 | $2,000 |
| Sanofi US Services Inc. | 1 | $1,262 |
| X4 Pharmaceuticals, Inc. | 1 | $1,250 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$478,199 in reported general payments places this provider in the 95th percentile of 46 pediatric hematology-oncology providers in District of Columbia.
See all pediatric hematology-oncology providers in District of Columbia →
Other pediatric hematology-oncology in Washington
- Michael GuerreraWashington$314K
- Deepika DarbariWashington$97K
- Naomi LubanWashington$27K
- Holly MeanyWashington$23K
- Anne AngiolilloWashington$22K
- Eugene HwangWashington$21K
- Gary KupferWashington$21K
- Catherine BollardWashington$15K
- James TaylorWashington$14K
- Suvankar MajumdarWashington$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.